Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: $20 million

So you agree that the Moore situation I suggest, exists ?

"Quid pro quo. If PTSC really would be liable to make a payment, let it come out of future proceeds on the same basis that Leckrone plans to 're-pay' PTSC. Leckrone should pay Chuck from TPL funds - isn't that where the agreement is as well as the litigation?

PTSC <-----> PDS <-----> TPL <-------> Chuck Moore"

I agree completely, if we have to compensate Chuck, that it would be in the same schedule of future proceedes..of which he will again be entitled to the first 15% plus retributionary payments, as a percentage of the gross (minus expenses and taxes.)

With Lekrones' slow and cut rate licensing fees, I'd say he's limited his liabilities, well, preceeding His and Moores' contentions. Lekrone is pretty sharp.

Share
New Message
Please login to post a reply